NP / PA
Wood, Karen
Wood, Karen was paid $345K by Medicaid between Jan 2021 and Dec 2024, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 65% of everything it billed.
33Billing provider infoWOOD, KAREN
MIDDLETOWN, RI 02842
MIDDLETOWN, RI 02842
33aNPI1144820077assigned 10/29/2020
33bProvider typePediatric Nurse Practitioner
28Total paid$345K
24GClaims6,135
24DCodes billed17
24AFirst – last monthJan 2021 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Rhode Island
Rank by total paid#4 of 28
Median peer was paid$49K
This provider vs. median7.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,524 | $60K | |
| 2022 | 1,597 | $82K | |
| 2023 | 1,723 | $117K | |
| 2024incomplete | 1,291 | $87K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 65% | 3,012 | 2,832 | $225K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 547 | 516 | $66K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 6.2% | 261 | 248 | $21K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 492 | 464 | $8K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 728 | 698 | $8K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 534 | 512 | $5K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 26 | 24 | $3K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 143 | 130 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 140 | 68 | $2K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 14 | 14 | $2K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 14 | 14 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 156 | 149 | $1K |
5 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.